Sarah McLaughlin

1.2k citations
17 papers · 783 · 1 hit paper · h-index 13

Impact in

Papers in

Sarah McLaughlin

17 papers receiving 771 citations

Sarah McLaughlin's Hit Papers

Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients 2015 · 265 citations
2650+3+7Years since publication50100150200250

Peers

Sarah McLaughlin
Comparison fields: 5 of 82
  • Pathology and Forensic Medicine 303
  • Immunology 310
  • Dermatology 104
  • Nephrology 45
  • Public Health, Environmental and Occupational Health 158
Replace C. Deligny with:
C. Deligny Martinique
Sara Şebnem Kılıç Türkiye
Arthur M.F. Yee United States
Ellen G. van Lochem Netherlands
J. Fraga Spain
Tirza Klein Israel
Susumu Nishinarita Japan
P Bird United Kingdom
Fiona Clark United Kingdom
Aryeh Metzker Israel
Sarah McLaughlin relative to C. Deligny Martinique C. Deligny's profile →
Citations per field
00.5×3.0×
C. Deligny · 1×
Citations per year

Countries citing papers authored by Sarah McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Sarah McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah McLaughlin more than expected).

Fields of papers citing papers by Sarah McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah McLaughlin. The network helps show where Sarah McLaughlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Sarah McLaughlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah McLaughlin Line = papers co-authored together Sarah McLaughlin links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Hit paper breakdown →
2015265
2 201586
3 201378
4 201568
5 201349
6 201845
7 201744
8 201744
9 201733
10 201720
11 201714
12 201713
13 202112
14 20196
15 20213
16 20222
17 20251

About Sarah McLaughlin

Sarah McLaughlin is a scholar working on Immunology, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine, Epidemiology and Oncology, having authored 17 papers that have together received 783 indexed citations. Recurring topics across this work include Malaria Research and Control (7 papers), Mosquito-borne diseases and control (5 papers), Invertebrate Immune Response Mechanisms (4 papers), Systemic Sclerosis and Related Diseases (4 papers), Immune Cell Function and Interaction (3 papers), T-cell and B-cell Immunology (2 papers), Eosinophilic Disorders and Syndromes (2 papers) and Mast cells and histamine (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (303 citations), Immunology (310 citations), Dermatology (104 citations), Nephrology (45 citations) and Public Health, Environmental and Occupational Health (158 citations). Sarah McLaughlin has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Robert Lafyatis, Cristina M. Padilla, Giuseppina Farina, Romy Christmann, Allison L. Mathes, Michael York, Jean Langhorne, Jessica Gordon, Michael L. Whitfield and Robert Spiera. Their work appears in journals such as Scientific Reports, Clinical Journal of the American Society of Nephrology, Annals of the Rheumatic Diseases, Journal of Investigative Dermatology and Journal of Pediatric Gastroenterology and Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact